Executive Summary On September 27, 2012, the Department of Health and Human Services Office of Inspector General (“OIG”) issued its findings resulting from a study of Medicare Part D billings and payments for Schedule II drug refills. Schedule II drugs have the highest potential for abuse of any prescription drug in the United States as…Read More
OIG Reminds Pharmacies of Proper Schedule II Billing Practices
Posted on September 28, 2012 in Health Law News
Published by: Hall Render